INmune Bio Inc. is a clinical stage biotechnology company that is developing new immunotherapies that reprogram a patientâs innate immune system to allow the immune system to fight cancer and Alzheimerâs. INmune Bio Inc. is a developing novel therapies targeting distinct parts of a patientâs innate immune system to fight disease. Drug candidates, INKmune⢠and INB03, may be used to treat cancer. XPro1595 targets neuroinflammation as a cause of Alzheimerâs disease. INmune Bioâs product platforms utilize a precision therapy approach, promoting the bodyâs innate immune response to treat unsolved problems in medicine. Source
No articles found.
 
                  As a leading manufacturer of medical devices and components, Atrion makes a wide r...
As a leading manufacturer of medical devices an...
 
                  Adverum is a clinical-stage gene therapy company targeting unmet medical need in o...
Adverum is a clinical-stage gene therapy compan...
 
                  G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on th...
G1 Therapeutics, Inc., is a clinical-stage biop...
 
                  Fresenius is a global healthcare group offering high-quality products and services...
Fresenius is a global healthcare group offering...
Headquartered in Bedford, Massachusetts, Anika Therapeutics, Inc. develops, manufa...
Headquartered in Bedford, Massachusetts, Anika ...
 
                  Integra LifeSciences, a world leader in medical devices, is dedicated to limiting ...
Integra LifeSciences, a world leader in medical...
We are a clinical-stage immuno-oncology company specializing in the development an...
We are a clinical-stage immuno-oncology company...
 
                  Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing ...
Trillium Therapeutics Inc. is a clinical stage ...
 
                  Precision BioSciences is dedicated to improving life (DTIL) through its proprietar...
Precision BioSciences is dedicated to improving...
 
                  Cancer is one of the most difficult diseases to treat. It is constantly changing, ...
Cancer is one of the most difficult diseases to...
Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...
Immunomedics is a clinical-stage biopharmaceuti...
 
                  Synthorx is a biotechnology company focused on prolonging and improving the lives ...
Synthorx is a biotechnology company focused on ...
 
                  We have used biochemical, molecular & cell biology and in vivo models to screen, i...
We have used biochemical, molecular & cell biol...
Join the National Investor Network and get the latest information with your interests in mind.